# Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients

> **NCT01944735** · PHASE1 · COMPLETED · sponsor: **Celtaxsys, Inc.** · enrollment: 17 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** CTX-4430
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01944735
- **Lead sponsor:** Celtaxsys, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-10
- **Final completion:** 2014-11
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2015-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01944735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01944735, "Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01944735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*